Patient-reported outcome measures (PROMs) in rhinology: a review of instruments, psychometric properties and clinical applications Review article

Main Article Content

Jakub Nicer
Antonina Nicer
Dariusz Jurkiewicz
Piotr A. Rot

Abstract

Patient-reported outcome measures have become the main way of assessing treatment effect in rhinology, where symptoms correlate only weakly with objective findings. This narrative review summarises the instruments used in chronic rhinosinusitis, nasal obstruction, rhinoplasty, allergic rhinitis and olfactory dysfunction, with their measurement properties, interpretive thresholds and the availability of validated Polish versions. Common pitfalls in interpretation are discussed.

Downloads

Download data is not yet available.

Article Details

How to Cite
Nicer, J., Nicer, A., Jurkiewicz, D., & Rot, P. A. (2026). Patient-reported outcome measures (PROMs) in rhinology: a review of instruments, psychometric properties and clinical applications. Alergoprofil. https://doi.org/10.24292/01.AP.222261026
Section
THERAPY

References

1. Weldring T, Smith SMS. Patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs). Health Serv Insights. 2013; 6: 61-8. https://doi.org/10.4137/HSI.S11093.
2. Ta NH, Gao J, Philpott C. A systematic review to examine the relationship between objective and patient-reported outcome measures in sinonasal disorders: recommendations for use in research and clinical practice. Int Forum Allergy Rhinol. 2021; 11(5): 910-23. https://doi.org/10.1002/alr.22744.
3. Fokkens WJ, Lund VJ, Hopkins C et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020; 58(Suppl. S29): 1-464. https://doi.org/10.4193/Rhin20.600.
4. Fokkens WJ, Viskens AS, Backer V et al. EPOS/EUFOREA update on indication and evaluation of biologics in chronic rhinosinusitis with nasal polyps 2023. Rhinology. 2023; 61(3): 194-202. https://doi.org/10.4193/Rhin22.489.
5. Mokkink LB, Terwee CB, Patrick DL et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res. 2010; 19(4): 539-49. https://doi.org/10.1007/s11136-010-9606-8.
6. Prinsen CAC, Mokkink LB, Bouter LM et al. COSMIN guideline for systematic reviews of patient-reported outcome measures. Qual Life Res. 2018; 27(5): 1147-57. https://doi.org/10.1007/s11136-018-1798-3.
7. Sedaghat AR. Understanding the minimal clinically important difference (MCID) of patient-reported outcome measures. Otolaryngol Head Neck Surg. 2019; 161(4): 551-60. https://doi.org/10.1177/0194599819852604.
8. Piccirillo JF, Merritt MG Jr, Richards ML. Psychometric and clinimetric validity of the 20-Item Sino-Nasal Outcome Test (SNOT-20). Otolaryngol Head Neck Surg. 2002; 126(1): 41-7. https://doi.org/10.1067/mhn.2002.121022.
9. Hopkins C, Gillett S, Slack R et al. Psychometric validity of the 22-item Sinonasal Outcome Test. Clin Otolaryngol. 2009; 34(5): 447-54. https://doi.org/10.1111/j.1749-4486.2009.01995.x .
10. Dejaco D, Riedl D, Huber A et al. The SNOT-22 factorial structure in European patients with chronic rhinosinusitis: new clinical insights. Eur Arch Otorhinolaryngol. 2019; 276(5): 1355-65. https://doi.org/10.1007/s00405-019-05320-z.
11. Phillips KM, Hoehle LP, Caradonna DS et al. Determinants of noticeable symptom improvement despite sub-MCID change in SNOT-22 score after treatment for chronic rhinosinusitis. Int Forum Allergy Rhinol. 2019; 9(5): 508-13. https://doi.org/10.1002/alr.22269.
12. Chowdhury NI, Mace JC, Bodner TE et al. Investigating the minimal clinically important difference for SNOT-22 symptom domains in surgically managed chronic rhinosinusitis. Int Forum Allergy Rhinol. 2017; 7(12): 1149-55. https://doi.org/10.1002/alr.22028.
13. Toma S, Hopkins C. Stratification of SNOT-22 scores into mild, moderate or severe and relationship with other subjective instruments. Rhinology. 2016; 54(2): 129-33. https://doi.org/10.4193/Rhino15.072.
14. Morawska J, Jeruzal-Świątecka J, Politański P et al. Sino-Nasal Outcome Test-22: translation, cross-cultural adaptation, and validation in Polish-speaking patients. Eur Arch Otorhinolaryngol. 2024; 281(12): 6431-43. https://doi.org/10.1007/s00405-024-08919-z.
15. Ghadersohi S, Price CPE, Jensen SE et al. Development and preliminary validation of a new patient-reported outcome measure for chronic rhinosinusitis (CRS-PRO). J Allergy Clin Immunol Pract. 2020; 8(7): 2341-50. https://doi.org/10.1016/j.jaip.2020.04.048.
16. Lin KA, Price CPE, Huang JH et al. Responsiveness and convergent validity of the chronic rhinosinusitis patient-reported outcome (CRS-PRO) measure in CRS patients undergoing endoscopic sinus surgery. Int Forum Allergy Rhinol. 2021; 11(9): 1308-20. https://doi.org/10.1002/alr.22782.
17. Zhang C, Zhang Q, Chen J et al. Patient-reported outcome measures as predictive tools for disease control in chronic rhinosinusitis with nasal polyps: a prospective study. Clin Transl Allergy. 2025; 15(11): e70119. https://doi.org/10.1002/clt2.70119.
18. Misirovs R, Chan R, Lipworth B. 5-Item sino-nasal outcome test and 22-item sino-nasal outcome test relationship with endoscopic and radiologic scores in chronic rhinosinusitis with nasal polyps. Ann Allergy Asthma Immunol. 2024; 132(3): 363-7. https://doi.org/10.1016/j.anai.2023.11.011.
19. Rudmik L, Hopkins C, Peters A et al. Patient-reported outcome measures for adult chronic rhinosinusitis: a systematic review and quality assessment. J Allergy Clin Immunol. 2015; 136(6): 1532-40.e2. https://doi.org/10.1016/j.jaci.2015.10.012.
20. Stewart MG, Witsell DL, Smith TL et al. Development and validation of the Nasal Obstruction Symptom Evaluation (NOSE) scale. Otolaryngol Head Neck Surg. 2004; 130(2): 157-63. https://doi.org/10.1016/j.otohns.2003.09.016.
21. Rhee JS, Sullivan CD, Frank DO et al. A systematic review of patient-reported nasal obstruction scores: defining normative and symptomatic ranges in surgical patients. JAMA Facial Plast Surg. 2014; 16(3): 219-25. https://doi.org/10.1001/jamafacial.2013.2473.
22. Kandathil CK, Saltychev M, Abdelwahab M et al. Minimal clinically important difference of the Standardized Cosmesis and Health Nasal Outcomes Survey. Aesthet Surg J. 2019; 39(8): 837-40. https://doi.org/10.1093/asj/sjz070.
23. Dąbrowska-Bień J, Skarżyński H, Gos E et al. Clinical evaluation of a Polish translation and cross-cultural adaptation of the Nasal Obstruction Symptom Evaluation (NOSE) scale. Med Sci Monit. 2018; 24: 7958-64. https://doi.org/10.12659/MSM.909934.
24. Moubayed SP, Ioannidis JPA, Saltychev M et al. The 10-item Standardized Cosmesis and Health Nasal Outcomes Survey (SCHNOS) for functional and cosmetic rhinoplasty. JAMA Facial Plast Surg. 2018; 20(1): 37-42. https://doi.org/10.1001/jamafacial.2017.1083.
25. Jadczak M, Krzywdzińska S, Jurkiewicz D. Polish translation and validation of the SCHNOS (Standardized Cosmesis and Health Nasal Outcomes Survey) questionnaire. Otolaryngol Pol. 2024; 78(4): 16-20. https://doi.org/10.5604/01.3001.0054.4820.
26. Velasquez N, Thamboo A, Habib ARR et al. The Empty Nose Syndrome 6-Item Questionnaire (ENS6Q): a validated 6-item questionnaire as a diagnostic aid for empty nose syndrome patients. Int Forum Allergy Rhinol. 2017; 7(1): 64-71. https://doi.org/10.1002/alr.21842.
27. Pfaar O, Demoly P, Gerth van Wijk R et al. Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper. Allergy. 2014; 69(7): 854-67. https://doi.org/10.1111/all.12383.
28. Pfaar O, Mösges R, Blaiss MS et al. The minimal clinically important difference in allergen immunotherapy: an evidence-based approach. Allergy. 2025; 80(12): 3369-76. https://doi.org/10.1111/all.16654.
29. Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy. 1991; 21(1): 77-83. https://doi.org/10.1111/j.1365-2222.1991.tb00807.x.
30. Juniper EF, Thompson AK, Ferrie PJ et al. Development and validation of the mini Rhinoconjunctivitis Quality of Life Questionnaire. Clin Exp Allergy. 2000; 30(1): 132-40. https://doi.org/10.1046/j.1365-2222.2000.00668.x.
31. Bousquet J, Schünemann HJ, Togias A et al. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases. Clin Transl Allergy. 2019; 9: 44. https://doi.org/10.1186/s13601-019-0279-2.
32. Schatz M, Meltzer EO, Nathan R et al. Psychometric validation of the Rhinitis Control Assessment Test: a brief patient- completed instrument for evaluating rhinitis symptom control. Ann Allergy Asthma Immunol. 2010; 104(2): 118-24. https://doi.org/10.1016/j.anai.2009.11.063.
33. Bousquet J, Anto JM, Bachert C et al. ARIA digital anamorphosis: digital transformation of health and care in airway diseases from research to practice. Allergy. 2021; 76(1): 168-90. https://doi.org/10.1111/all.14422.
34. Husain Q, Hoehle L, Phillips K et al. The 22-item Sinonasal Outcome Test as a tool for the assessment of quality of life and symptom control in allergic rhinitis. Am J Rhinol Allergy. 2020; 34(2): 209-16. https://doi.org/10.1177/1945892419884789.
35. Mattos JL, Edwards C, Schlosser RJ et al. A brief version of the questionnaire of olfactory disorders in patients with chronic rhinosinusitis. Int Forum Allergy Rhinol. 2019; 9(10): 1144-50. https://doi.org/10.1002/alr.22392.
36. Mattos JL, Bodner TE, Mace JC et al. Psychometric properties of the brief version of the questionnaire of olfactory disorders in patients with chronic rhinosinusitis. Int Forum Allergy Rhinol. 2021; 11(10): 1436-42. https://doi.org/10.1002/alr.22800.
37. Kay DJ, Rosenfeld RM. Quality of life for children with persistent sinonasal symptoms. Otolaryngol Head Neck Surg. 2003; 128(1): 17-26. https://doi.org/10.1067/mhn.2003.41.
38. Williams E, Rotimi O, Burrows L et al. Content validity of patient-reported outcome measures developed for assessing disease-specific quality of life in children with sinonasal disease: a systematic review. Int Forum Allergy Rhinol. 2025; 15(3): 317-27. https://doi.org/10.1002/alr.23539.